Translated Impact on Carbon Footprint from Choice of Inhaled Therapy: a Danish Scenario
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Woodcock A, Beeh K, Sagara H, Aumonier S, Addo-Yobo E, Khan J
. The environmental impact of inhaled therapy: making informed treatment choices. Eur Respir J. 2021; 60(1).
PMC: 9301054.
DOI: 10.1183/13993003.02106-2021.
View
2.
Janson C, Henderson R, Lofdahl M, Hedberg M, Sharma R, Wilkinson A
. Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax. 2019; 75(1):82-84.
PMC: 6929707.
DOI: 10.1136/thoraxjnl-2019-213744.
View
3.
Woodcock A, Janson C, Rees J, Frith L, Lofdahl M, Moore A
. Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis. Thorax. 2022; 77(12):1187-1192.
PMC: 9685707.
DOI: 10.1136/thoraxjnl-2021-218088.
View
4.
Usmani O, Lavorini F, Marshall J, Dunlop W, Heron L, Farrington E
. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018; 19(1):10.
PMC: 5771074.
DOI: 10.1186/s12931-017-0710-y.
View
5.
Wilkinson A, Braggins R, Steinbach I, Smith J
. Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. BMJ Open. 2019; 9(10):e028763.
PMC: 6830591.
DOI: 10.1136/bmjopen-2018-028763.
View